ASHLEY FULTZ: Open Payments
NPI 1457694960 · MIDDLESBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 22 payments from 12 companies in 2025. Trend: 2023 $556 · 2024 $645 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $117 |
| PFIZER INC. | 3 | $55 |
| Novo Nordisk Inc | 3 | $54 |
| Lundbeck LLC | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Ardelyx, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: VRAYLAR, Ozempic, REXULTI, ELIQUIS, QULIPTA, TRELEGY ELLIPTA, VOQUEZNA, IBSRELA.
Industry payments across KY — which companies pay providers there.
